We are proud of and thankful for prominent scientists and clinicians who have decided to dedicate some of their academic time to research on Moleac’s products through initiatives such as the CHIMES trial. As academic partners, they are fully independent.

SCIENTIFIC ADVISORY BOARD

Prof Michel Lazdunski, CNRS France Gold Medal– World renowned specialist in pharmacology of ion channels

Prof Christopher Chen, National University of Singapore, Chairman of the CHIMES Trial Steering Committee, Principal Investigator of NEURITES Trial

Prof Marie-Germaine Bousser, Former Head of Neurology at Lariboisiere Hospital, France, investigator of CHIMES Trial

Dr Catherine Heurteaux, Principal Investigator at IPMC

Prof Geoffrey Donnan, National Stroke Institute, University of Melbourne, Australia

Prof Hossein Pakdaman, Shahid Behesti University, Tehran

Dr Valery Feigin, Director of the National Institute for Stroke and Applied Neurosciences (NISAN), New Zealand

Prof Professor Lawrence Wong, Head of Department of Medicine and Therapeutics, Hong Kong